Publications by authors named "Jernej Pusnik"

Several studies have suggested the imprinting of SARS-CoV-2 immunity by original immune challenge without addressing the formation of the de novo response to successive antigen exposures. As this is crucial for the development of the original antigenic sin, we assessed the immune response against the mutated epitopes of omicron SARS-CoV-2 after vaccine breakthrough. Our data demonstrate a robust humoral response in thrice-vaccinated individuals following omicron breakthrough which is a recall of vaccine-induced memory.

View Article and Find Full Text PDF
Article Synopsis
  • Vaccination campaigns worldwide have significantly reduced deaths from SARS-CoV-2 and mRNA vaccines provoke strong immune responses that protect against severe illness.* -
  • A study followed adaptive immune responses for 12 months after initial mRNA vaccination, finding a rapid decline in antibodies but an increase in memory B cells; T cell responses remained stable.* -
  • A booster dose notably improved antibody levels and neutralization capacity, especially against the omicron variant, enhancing both memory B cells and T cell responses.*
View Article and Find Full Text PDF
Article Synopsis
  • The study examines the immunity of individuals who received two doses of an mRNA vaccine alongside different experiences with breakthrough infections and booster doses.
  • It finds that either recovering from a delta variant infection or receiving a booster improves B cell immunity significantly more than just two vaccine doses, especially in the case of breakthrough infections with the omicron variant.
  • Additionally, hybrid immunity from a combination of vaccination and infection leads to better overall immune response than vaccination alone, while T cell responses remain largely unaffected by further exposures.
View Article and Find Full Text PDF

Robust population-wide immunity will help to curb the SARS-CoV-2 pandemics. To maintain the immunity at protective levels, the quality and persistence of the immune response elicited by infection or vaccination must be determined. We analyzed the dynamics of B cell response during 12 months following SARS-CoV-2 infection on an individual level.

View Article and Find Full Text PDF

Memory B cells seem to be more durable than antibodies and thus crucial for the long-term immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Here we investigate SARS-CoV-2 spike-specific memory B cells and their dependence on CD4 T cell help in different settings of coronavirus disease 2019 (COVID-19). Compared with severely ill individuals, those who recovered from mild COVID-19 develop fewer but functionally superior spike-specific memory B cells.

View Article and Find Full Text PDF

Antibodies with a functional Fc region were previously associated with protection from HIV-1 acquisition and spontaneous suppression of viral replication. Unlike broadly neutralizing antibodies, they are not restricted to neutralizing epitopes and do not require unconventional structural traits to exert their antiviral activity. They, therefore, develop earlier after infection and can be detected in the majority of cases.

View Article and Find Full Text PDF

Acute HIV-1 infection is characterized by high viremia and massive depletion of CD4 T cells throughout all tissue compartments. During this time the latent viral reservoir is established but the dynamics of memory CD4 T cell subset development, their infectability and influence on disease progression during acute HIV-1 infection has not been carefully described. We therefore investigated the dynamics of CD4 T cell memory populations in the RV217 (ECHO) cohort during the acute phase of infection.

View Article and Find Full Text PDF